USPTO serial 99526431

MDREVIEWER

Status 641Office Action

Need help with MDREVIEWER?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: November 25, 2026

The USPTO examiner issued refusals based on likelihood of confusion with existing registrations and the descriptiveness of your trademark wording.

Class	Description	Status	First use
042	Software as a service (SAAS) services featuring software for collecting, analyzing, and reporting physician-verified clinical reviews and real-world evidence for pharmaceutical products and medical therapies, and for providing predictive analytics and intelligence regarding therapeutic effectiveness, prescriber behavior, competitive benchmarking, and market access barriers in the pharmaceutical and life sciences industries	ACTIVE	Mar 9, 2025

Date	Code	Event
Aug 25, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2026	GNRT	NON-FINAL ACTION E-MAILED
Aug 25, 2026	CNRT	NON-FINAL ACTION WRITTEN
Jul 6, 2026	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2026	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2026	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2026	GNRT	NON-FINAL ACTION E-MAILED
Apr 21, 2026	CNRT	NON-FINAL ACTION WRITTEN
Apr 6, 2026	DOCK	ASSIGNED TO EXAMINER
Feb 12, 2026	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2025	MAFR	APPLICATION FILING RECEIPT MAILED
Dec 2, 2025	NWAP	NEW APPLICATION ENTERED